Correlation Between Puma Biotechnology and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Molecular Partners AG, you can compare the effects of market volatilities on Puma Biotechnology and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Molecular Partners.
Diversification Opportunities for Puma Biotechnology and Molecular Partners
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Puma and Molecular is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Molecular Partners go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Molecular Partners
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.26 times more return on investment than Molecular Partners. However, Puma Biotechnology is 1.26 times more volatile than Molecular Partners AG. It trades about 0.08 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.09 per unit of risk. If you would invest 278.00 in Puma Biotechnology on October 20, 2024 and sell it today you would earn a total of 19.00 from holding Puma Biotechnology or generate 6.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. Molecular Partners AG
Performance |
| Timeline |
| Puma Biotechnology |
| Molecular Partners |
Puma Biotechnology and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Molecular Partners
The main advantage of trading using opposite Puma Biotechnology and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance |